# Medical Research Agency, Poland

Organization · id `cardio:org-medical-research-agency-poland` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Medical+Research+Agency%2C+Poland>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class other government. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Medical Research Agency, Poland
- Sponsor class: OTHER\_GOV

## Connected pages

- Sponsors: Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure (`cardio:ct-nct03445949`)
- Sponsors: Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome (`cardio:ct-nct04718025`)
- Sponsors: Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions (`cardio:ct-nct05305612`)
- Sponsors: Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) (`cardio:ct-nct05465031`)
- Sponsors: Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction (`cardio:ct-nct05487261`)
- Sponsors: Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI (`cardio:ct-nct05966675`)
- Sponsors: Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes (`cardio:ct-nct07254572`)

## Provenance

Content hash: dcc801e955bbd3df5629db5970f76eb8417aa8b6ccc063825f80506456c4019a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
